Skip to main content

Table 1 Baseline patient data

From: Prediction of recurrent stroke with ABCD2 and ABCD3 scores in patients with symptomatic 50-99% carotid stenosis

  All (n = 230)
Men n (%) 147 (64%)
Age, years mean (SD) 71 (7.7)
50-69% symptomatic carotid stenosis n (%) 54 (23%)
70-99% symptomatic carotid stenosis n (%) 176 (77%)
First recorded systolic blood pressure mean (SD) 160 (29)
First recorded diastolic blood pressure mean (SD) 82 (16)
Presenting event: Stroke n (%) 96 (42%)
Presenting event: Retinal artery occlusion n (%) 12 (5%)
Presenting event: TIA n (%) 70 (30%)
Presenting event: Amaurosis fugax n (%) 52 (23%)
Anti-platelet or anti-coagulant at first health care contact n (%) 130 (57%)
Anti-platelet or anti-coagulant at 2 days after first health care contact n (%) 195 (85%)
Anti-platelet or anti-coagulant at 7 days after first health care contact n (%) 214 (93%)
Blood-pressure lowering medication at first health care contact n (%) 189 (82%)
Blood-pressure lowering medication at 2 days after first health care contact n (%) 198 (86%)
Blood-pressure lowering medication at 7 days after first health care contact n (%) 205 (89%)
Lipid lowering medication at first health care contact n (%) 99 (43%)
Lipid lowering medication at 2 days after first health care contact n (%) 142 (62%)
Lipid lowering medication at 7 days after first health care contact n (%) 176 (77%)
Underwent CEA or carotid angioplasty n (%) 183 (80%)
Delay between presenting event and first health care contact, days median (IQR) 0 (0-2)
Delay between presenting event and CEA or carotid angioplasty, weeks median (IQR) 4.1 (2.4-7.1)
CEA or carotid angioplasty within 2 days of the presenting event 1 (0.4%)
CEA or carotid angioplasty within 7 days of the presenting event 10 (4%)
CEA or carotid angioplasty within 14 days of the presenting event 36 (16%)
Recurrent ipsilateral ischemic stroke n (%) 25 (11%)